← FDA Drug Approvals (Drugs@FDA)
SILDENAFIL CITRATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS INC · Approved 2020-11-25
Drug application
- FDA Application #
ANDA202506- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SILDENAFIL CITRATE
- Generic name
- Sildenafil Citrate
- Active ingredients
- SILDENAFIL CITRATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- WATSON LABS INC
- First approval
- 2020-11-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown